ABRAXANE 100 mg/20mL
Paclitaxel · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Abraxis BioScience, LLC
ABRAXANE is a injection, powder, lyophilized, for suspension containing paclitaxel at 100 mg/20mL, taken intravenous. Manufactured by Abraxis BioScience, LLC.
Key Facts
- Brand Name
- ABRAXANE
- Generic Name
- Paclitaxel
- NDC Code (Product)
68817-134- Manufacturer
- Abraxis BioScience, LLC
- Strength
- 100 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA021660
- Drug Class
- Microtubule Inhibitor [EPC]
- Marketing Start
- 02/10/2005
Recall History
No Recall HistoryFrequently Asked Questions
What is ABRAXANE used for?
ABRAXANE contains Paclitaxel. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is ABRAXANE a controlled substance?
ABRAXANE is not classified as a controlled substance by the DEA.
What is the generic name for ABRAXANE?
The generic name for ABRAXANE is Paclitaxel. There are 12 other brand versions of Paclitaxel.
What is the NDC code for ABRAXANE 100 mg/20mL?
The NDC (National Drug Code) for ABRAXANE 100 mg/20mL is 68817-134, listed by Abraxis BioScience, LLC.
Other Paclitaxel Brands
See all →- Paclitaxel100 mg/20mL0480-3290
- Paclitaxel6 mg/mL0703-3216
- Paclitaxel6 mg/mL0703-3217
- PACLITAXEL PACLITAXEL6 mg/mL23155-882
- Paclitaxel6 mg/mL61703-342
- Paclitaxel6 mg/mL68001-705
- Paclitaxel100 mg/100mg75007-041
- Paclitaxel6 mg/mL46708-622
- PACLITAXEL PACLITAXEL6 mg/mL68083-179
- Paclitaxel protein-bound particles100 mg/20mL69097-398
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)